Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Neuromyelitis optica spectrum disorder: Patient experience and quality of life.

Beekman J, Keisler A, Pedraza O, Haramura M, Gianella-Borradori A, Katz E, Ratchford JN, Barron G, Cook LJ, Behne JM, Blaschke TF, Smith TJ, Yeaman MR.

Neurol Neuroimmunol Neuroinflamm. 2019 Jun 20;6(4):e580. doi: 10.1212/NXI.0000000000000580. eCollection 2019 Jul.

2.

A proteomic signature for dementia with Lewy bodies.

O'Bryant SE, Ferman TJ, Zhang F, Hall J, Pedraza O, Wszolek ZK, Como T, Julovich D, Mattevada S, Johnson LA, Edwards M, Hall J, Graff-Radford NR.

Alzheimers Dement (Amst). 2019 Mar 15;11:270-276. doi: 10.1016/j.dadm.2019.01.006. eCollection 2019 Dec.

3.

Ethnoracial differences in Alzheimer's disease from the FLorida Autopsied Multi-Ethnic (FLAME) cohort.

Santos OA, Pedraza O, Lucas JA, Duara R, Greig-Custo MT, Hanna Al-Shaikh FS, Liesinger AM, Bieniek KF, Hinkle KM, Lesser ER, Crook JE, Carrasquillo MM, Ross OA, Ertekin-Taner N, Graff-Radford NR, Dickson DW, Murray ME.

Alzheimers Dement. 2019 May;15(5):635-643. doi: 10.1016/j.jalz.2018.12.013. Epub 2019 Feb 18.

4.

Temporal trends and characteristics of clinical trials for which only one racial or ethnic group is eligible.

Egleston BL, Pedraza O, Wong YN, Griffin CL, Ross EA, Beck JR.

Contemp Clin Trials Commun. 2018 Jan 31;9:135-142. doi: 10.1016/j.conctc.2018.01.004. eCollection 2018 Mar.

5.

Daytime sleepiness in dementia with Lewy bodies is associated with neuronal depletion of the nucleus basalis of Meynert.

Kasanuki K, Ferman TJ, Murray ME, Heckman MG, Pedraza O, Hanna Al-Shaikh FS, Mishima T, Diehl NN, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford NR, Dickson DW.

Parkinsonism Relat Disord. 2018 May;50:99-103. doi: 10.1016/j.parkreldis.2018.02.003. Epub 2018 Feb 3.

6.

Mild cognitive impairment (MCI) and dementia in a sample of adults in the city of Bogotá.

Pedraza OL, Montes AMS, Sierra FA, Montalvo MC, Muñoz Y, Díaz JM, Lozano A, Piñeros C.

Dement Neuropsychol. 2017 Jul-Sep;11(3):262-269. doi: 10.1590/1980-57642016dn11-030008.

7.

The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.

Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA, Uitti RJ, Wszolek ZK, Graff-Radford J, Pedraza O, Kantarci K, Boeve BF, Dickson DW.

Alzheimers Dement. 2018 Mar;14(3):330-339. doi: 10.1016/j.jalz.2017.09.014. Epub 2017 Oct 31.

8.

African American exome sequencing identifies potential risk variants at Alzheimer disease loci.

N'Songo A, Carrasquillo MM, Wang X, Burgess JD, Nguyen T, Asmann YW, Serie DJ, Younkin SG, Allen M, Pedraza O, Duara R, Greig Custo MT, Graff-Radford NR, Ertekin-Taner N.

Neurol Genet. 2017 Apr 7;3(2):e141. doi: 10.1212/NXG.0000000000000141. eCollection 2017 Apr.

9.

Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72-associated amyotrophic lateral sclerosis.

Gendron TF, Chew J, Stankowski JN, Hayes LR, Zhang YJ, Prudencio M, Carlomagno Y, Daughrity LM, Jansen-West K, Perkerson EA, O'Raw A, Cook C, Pregent L, Belzil V, van Blitterswijk M, Tabassian LJ, Lee CW, Yue M, Tong J, Song Y, Castanedes-Casey M, Rousseau L, Phillips V, Dickson DW, Rademakers R, Fryer JD, Rush BK, Pedraza O, Caputo AM, Desaro P, Palmucci C, Robertson A, Heckman MG, Diehl NN, Wiggs E, Tierney M, Braun L, Farren J, Lacomis D, Ladha S, Fournier CN, McCluskey LF, Elman LB, Toledo JB, McBride JD, Tiloca C, Morelli C, Poletti B, Solca F, Prelle A, Wuu J, Jockel-Balsarotti J, Rigo F, Ambrose C, Datta A, Yang W, Raitcheva D, Antognetti G, McCampbell A, Van Swieten JC, Miller BL, Boxer AL, Brown RH, Bowser R, Miller TM, Trojanowski JQ, Grossman M, Berry JD, Hu WT, Ratti A, Traynor BJ, Disney MD, Benatar M, Silani V, Glass JD, Floeter MK, Rothstein JD, Boylan KB, Petrucelli L.

Sci Transl Med. 2017 Mar 29;9(383). pii: eaai7866. doi: 10.1126/scitranslmed.aai7866.

10.

LRRK2 variation and dementia with Lewy bodies.

Heckman MG, Soto-Ortolaza AI, Contreras MYS, Murray ME, Pedraza O, Diehl NN, Walton R, Labbé C, Lorenzo-Betancor O, Uitti RJ, van Gerpen J, Ertekin-Taner N, Smith GE, Kantarci K, Savica R, Jones DT, Graff-Radford J, Knopman DS, Lowe VJ, Jack CR Jr, Petersen RC, Parisi JE, Rademakers R, Wszolek ZK, Graff-Radford NR, Ferman TJ, Dickson DW, Boeve BF, Ross OA.

Parkinsonism Relat Disord. 2016 Oct;31:98-103. doi: 10.1016/j.parkreldis.2016.07.015. Epub 2016 Jul 29.

11.

Validity and reliability of the NAB Naming Test.

Sachs BC, Rush BK, Pedraza O.

Clin Neuropsychol. 2016 May;30(4):629-38. doi: 10.1080/13854046.2016.1149618. Epub 2016 Mar 30.

PMID:
27030079
12.

A Novel Tau Mutation in Exon 12, p.Q336H, Causes Hereditary Pick Disease.

Tacik P, DeTure M, Hinkle KM, Lin WL, Sanchez-Contreras M, Carlomagno Y, Pedraza O, Rademakers R, Ross OA, Wszolek ZK, Dickson DW.

J Neuropathol Exp Neurol. 2015 Nov;74(11):1042-52. doi: 10.1097/NEN.0000000000000248.

13.

Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers.

Gendron TF, van Blitterswijk M, Bieniek KF, Daughrity LM, Jiang J, Rush BK, Pedraza O, Lucas JA, Murray ME, Desaro P, Robertson A, Overstreet K, Thomas CS, Crook JE, Castanedes-Casey M, Rousseau L, Josephs KA, Parisi JE, Knopman DS, Petersen RC, Boeve BF, Graff-Radford NR, Rademakers R, Lagier-Tourenne C, Edbauer D, Cleveland DW, Dickson DW, Petrucelli L, Boylan KB.

Acta Neuropathol. 2015 Oct;130(4):559-73. doi: 10.1007/s00401-015-1474-4. Epub 2015 Sep 8.

14.

Characteristics of clinical trials that require participants to be fluent in English.

Egleston BL, Pedraza O, Wong YN, Dunbrack RL Jr, Griffin CL, Ross EA, Beck JR.

Clin Trials. 2015 Dec;12(6):618-26. doi: 10.1177/1740774515592881. Epub 2015 Jul 7.

15.

Mini-Mental State Examination (MMSE) for the detection of Alzheimer's disease and other dementias in people with mild cognitive impairment (MCI).

Arevalo-Rodriguez I, Smailagic N, Roqué I Figuls M, Ciapponi A, Sanchez-Perez E, Giannakou A, Pedraza OL, Bonfill Cosp X, Cullum S.

Cochrane Database Syst Rev. 2015 Mar 5;(3):CD010783. doi: 10.1002/14651858.CD010783.pub2. Review.

16.

Late-onset Alzheimer's risk variants in memory decline, incident mild cognitive impairment, and Alzheimer's disease.

Carrasquillo MM, Crook JE, Pedraza O, Thomas CS, Pankratz VS, Allen M, Nguyen T, Malphrus KG, Ma L, Bisceglio GD, Roberts RO, Lucas JA, Smith GE, Ivnik RJ, Machulda MM, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2015 Jan;36(1):60-7. doi: 10.1016/j.neurobiolaging.2014.07.042. Epub 2014 Aug 4.

17.

Concurrent variably protease-sensitive prionopathy and amyotrophic lateral sclerosis.

Cannon A, Bieniek KF, Lin WL, Notari S, Zou WQ, Gambetti P, Pedraza O, Graff-Radford NR, Ferman TJ, Dickson DW.

Acta Neuropathol. 2014 Aug;128(2):313-315. doi: 10.1007/s00401-014-1309-8. Epub 2014 Jun 14. No abstract available.

18.

Nonamnestic mild cognitive impairment progresses to dementia with Lewy bodies.

Ferman TJ, Smith GE, Kantarci K, Boeve BF, Pankratz VS, Dickson DW, Graff-Radford NR, Wszolek Z, Van Gerpen J, Uitti R, Pedraza O, Murray ME, Aakre J, Parisi J, Knopman DS, Petersen RC.

Neurology. 2013 Dec 3;81(23):2032-8. doi: 10.1212/01.wnl.0000436942.55281.47. Epub 2013 Nov 8.

19.

Evaluation of memory endophenotypes for association with CLU, CR1, and PICALM variants in black and white subjects.

Pedraza O, Allen M, Jennette K, Carrasquillo M, Crook J, Serie D, Pankratz VS, Palusak R, Nguyen T, Malphrus K, Ma L, Bisceglio G, Roberts RO, Lucas JA, Ivnik RJ, Smith GE, Graff-Radford NR, Petersen RC, Younkin SG, Ertekin-Taner N.

Alzheimers Dement. 2014 Mar;10(2):205-13. doi: 10.1016/j.jalz.2013.01.016. Epub 2013 May 2.

20.

Alzheimer's disease dementia guidelines for diagnostic testing: a systematic review.

Arevalo-Rodriguez I, Pedraza OL, Rodríguez A, Sánchez E, Gich I, Solà I, Bonfill X, Alonso-Coello P.

Am J Alzheimers Dis Other Demen. 2013 Mar;28(2):111-9. doi: 10.1177/1533317512470209. Epub 2013 Jan 2. Review.

PMID:
23288575
21.

Imaging and acetylcholinesterase inhibitor response in dementia with Lewy bodies.

Graff-Radford J, Boeve BF, Pedraza O, Ferman TJ, Przybelski S, Lesnick TG, Vemuri P, Senjem ML, Smith GE, Knopman DS, Lowe V, Jack CR Jr, Petersen RC, Kantarci K.

Brain. 2012 Aug;135(Pt 8):2470-7. doi: 10.1093/brain/aws173. Epub 2012 Jul 18.

22.

Characterization of frontotemporal dementia and/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72.

Boeve BF, Boylan KB, Graff-Radford NR, DeJesus-Hernandez M, Knopman DS, Pedraza O, Vemuri P, Jones D, Lowe V, Murray ME, Dickson DW, Josephs KA, Rush BK, Machulda MM, Fields JA, Ferman TJ, Baker M, Rutherford NJ, Adamson J, Wszolek ZK, Adeli A, Savica R, Boot B, Kuntz KM, Gavrilova R, Reeves A, Whitwell J, Kantarci K, Jack CR Jr, Parisi JE, Lucas JA, Petersen RC, Rademakers R.

Brain. 2012 Mar;135(Pt 3):765-83. doi: 10.1093/brain/aws004.

23.

Reliable change on the Boston naming test.

Sachs BC, Lucas JA, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR, Pedraza O.

J Int Neuropsychol Soc. 2012 Mar;18(2):375-8. doi: 10.1017/S1355617711001810. Epub 2012 Jan 23.

24.

Diagnostic validity of age and education corrections for the Mini-Mental State Examination in older African Americans.

Pedraza O, Clark JH, O'Bryant SE, Smith GE, Ivnik RJ, Graff-Radford NR, Willis FB, Petersen RC, Lucas JA.

J Am Geriatr Soc. 2012 Feb;60(2):328-31. doi: 10.1111/j.1532-5415.2011.03766.x. Epub 2011 Dec 8.

25.

Inclusion of RBD improves the diagnostic classification of dementia with Lewy bodies.

Ferman TJ, Boeve BF, Smith GE, Lin SC, Silber MH, Pedraza O, Wszolek Z, Graff-Radford NR, Uitti R, Van Gerpen J, Pao W, Knopman D, Pankratz VS, Kantarci K, Boot B, Parisi JE, Dugger BN, Fujishiro H, Petersen RC, Dickson DW.

Neurology. 2011 Aug 30;77(9):875-82. doi: 10.1212/WNL.0b013e31822c9148. Epub 2011 Aug 17.

26.

Difficulty and discrimination parameters of Boston naming test items in a consecutive clinical series.

Pedraza O, Sachs BC, Ferman TJ, Rush BK, Lucas JA.

Arch Clin Neuropsychol. 2011 Aug;26(5):434-44. doi: 10.1093/arclin/acr042. Epub 2011 May 18.

27.

Multiple, correlated covariates associated with differential item functioning (DIF): Accounting for language DIF when education levels differ across languages.

Gibbons LE, Crane PK, Mehta KM, Pedraza O, Tang Y, Manly JJ, Narasimhalu K, Teresi J, Jones RN, Mungas D.

Ageing Res. 2011 Apr 28;2(1):19-25.

28.

Association of common KIBRA variants with episodic memory and AD risk.

Burgess JD, Pedraza O, Graff-Radford NR, Hirpa M, Zou F, Miles R, Nguyen T, Li M, Lucas JA, Ivnik RJ, Crook J, Pankratz VS, Dickson DW, Petersen RC, Younkin SG, Ertekin-Taner N.

Neurobiol Aging. 2011 Mar;32(3):557.e1-9. doi: 10.1016/j.neurobiolaging.2010.11.004. Epub 2010 Dec 24.

29.

Robust and expanded norms for the Dementia Rating Scale.

Pedraza O, Lucas JA, Smith GE, Petersen RC, Graff-Radford NR, Ivnik RJ.

Arch Clin Neuropsychol. 2010 Aug;25(5):347-58. doi: 10.1093/arclin/acq030. Epub 2010 Apr 28.

30.

Internal Consistency and Test-Retest Stability of the Geriatric Depression Scale-Short Form in African American Older Adults.

Pedraza O, Dotson VM, Willis FB, Graff-Radford NR, Lucas JA.

J Psychopathol Behav Assess. 2009 Dec 1;31(4):412-416.

31.

Differential item functioning of the Boston Naming Test in cognitively normal African American and Caucasian older adults.

Pedraza O, Graff-Radford NR, Smith GE, Ivnik RJ, Willis FB, Petersen RC, Lucas JA.

J Int Neuropsychol Soc. 2009 Sep;15(5):758-68. doi: 10.1017/S1355617709990361. Epub 2009 Jul 2.

32.

Improving the reliability of manual and automated methods for hippocampal and amygdala volume measurements.

Hasan KM, Pedraza O.

Neuroimage. 2009 Nov 15;48(3):497-8. doi: 10.1016/j.neuroimage.2009.05.004. Epub 2009 May 13. No abstract available.

33.

Measurement in cross-cultural neuropsychology.

Pedraza O, Mungas D.

Neuropsychol Rev. 2008 Sep;18(3):184-93. doi: 10.1007/s11065-008-9067-9. Epub 2008 Sep 24. Review.

34.

Composite scores for executive function items: demographic heterogeneity and relationships with quantitative magnetic resonance imaging.

Crane PK, Narasimhalu K, Gibbons LE, Pedraza O, Mehta KM, Tang Y, Manly JJ, Reed BR, Mungas DM.

J Int Neuropsychol Soc. 2008 Sep;14(5):746-59. doi: 10.1017/S1355617708081162.

35.

Evaluation of subclinical cerebral injury and neuropsychologic function in patients undergoing carotid endarterectomy.

Falkensammer J, Oldenburg WA, Hendrzak AJ, Neuhauser B, Pedraza O, Ferman T, Klocker J, Biebl M, Hugl B, Meschia JF, Hakaim AG, Brott TG.

Ann Vasc Surg. 2008 Jul-Aug;22(4):497-504. doi: 10.1016/j.avsg.2008.01.013. Epub 2008 May 27.

PMID:
18504102
36.

Reliable change on the Dementia Rating Scale.

Pedraza O, Smith GE, Ivnik RJ, Willis FB, Ferman TJ, Petersen RC, Graff-Radford NR, Lucas JA.

J Int Neuropsychol Soc. 2007 Jul;13(4):716-20. Epub 2007 May 18.

PMID:
17521486
37.

Faces of emotion in Parkinsons disease: micro-expressivity and bradykinesia during voluntary facial expressions.

Bowers D, Miller K, Bosch W, Gokcay D, Pedraza O, Springer U, Okun M.

J Int Neuropsychol Soc. 2006 Nov;12(6):765-73.

PMID:
17064440
38.

Mayo's older African American normative studies: confirmatory factor analysis of a core battery.

Pedraza O, Lucas JA, Smith GE, Willis FB, Graff-Radford NR, Ferman TJ, Petersen RC, Bowers D, Ivnik RJ.

J Int Neuropsychol Soc. 2005 Mar;11(2):184-91.

PMID:
15962706
39.

Asymmetry of the hippocampus and amygdala in MRI volumetric measurements of normal adults.

Pedraza O, Bowers D, Gilmore R.

J Int Neuropsychol Soc. 2004 Sep;10(5):664-78.

PMID:
15327714
40.

Development and initial validation of a screening tool for Parkinson disease surgical candidates.

Okun MS, Fernandez HH, Pedraza O, Misra M, Lyons KE, Pahwa R, Tarsy D, Scollins L, Corapi K, Friehs GM, Grace J, Romrell J, Foote KD.

Neurology. 2004 Jul 13;63(1):161-3.

PMID:
15249630
41.

Differential profiles of verbal learning in traumatic brain injury.

Demery JA, Pedraza O, Hanlon RE.

J Clin Exp Neuropsychol. 2002 Sep;24(6):818-27.

PMID:
12424655
42.

Amantadine hydrochloride treatment in olivopontocerebellar atrophy: a long-term follow-up study.

Botez MI, Botez-Marquard T, Elie R, Le Marec N, Pedraza OL, Lalonde R.

Eur Neurol. 1999;41(4):212-5.

PMID:
10343152
43.

[Clinical identification of hereditary ataxias. A study of 38 cases in Colombia].

Pedraza OL, Prieto JC, Casasbuenas OL, Espinosa E.

Rev Neurol. 1997 Jul;25(143):1016-22. Spanish.

PMID:
9280625
44.

Amantadine hydrochloride treatment in heredodegenerative ataxias: a double blind study.

Botez MI, Botez-Marquard T, Elie R, Pedraza OL, Goyette K, Lalonde R.

J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):259-64.

45.

Radiologic correlates of reaction time measurements in olivopontocerebellar atrophy.

Botez MI, Pedraza OL, Botez-Marquard T, Vézina JL, Elie R.

Eur Neurol. 1993;33(4):304-9.

PMID:
8348918
46.

Thiamine status in inherited degenerative ataxias.

Pedraza OL, Botez MI.

J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):136-7.

47.

Treatment of heredo-degenerative ataxias with amantadine hydrochloride.

Botez MI, Young SN, Botez T, Pedraza OL.

Can J Neurol Sci. 1991 Aug;18(3):307-11.

PMID:
1913365

Supplemental Content

Loading ...
Support Center